WellDoc BlueStar
The new clearance expands its insulin dosing support to bolus and premixed insulin titration for Type 2 diabetes.
Healthcare providers use a web interface to prescribe an initial dose "and BlueStar does the rest," according to Welldoc's chief medical officer.
Also: Consumer survey suggests declining digital health engagement; Iran's COVID-19 app pulled from Play Store after malware accusations.
This is the seventh FDA clearance for the longstanding mobile diabetes management platform.